(19)
(11) EP 4 251 633 A1

(12)

(43) Date of publication:
04.10.2023 Bulletin 2023/40

(21) Application number: 21896011.0

(22) Date of filing: 25.11.2021
(51) International Patent Classification (IPC): 
C07H 19/20(2006.01)
A61P 35/00(2006.01)
A61K 31/7076(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07H 19/20; A61K 45/06
(86) International application number:
PCT/CA2021/051688
(87) International publication number:
WO 2022/109741 (02.06.2022 Gazette 2022/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 25.11.2020 CN 202011346141
23.12.2020 US 202017133348

(71) Applicant: Risen (Suzhou) Pharma Tech Co., Ltd.
Suzhou, Jiangsu 215123 (CN)

(72) Inventors:
  • ZHANG, Yuhua
    Suzhou, Jiangsu 215000 (CN)
  • HUANG, Chuanhao
    Suzhou, Jiangsu 215000 (CN)
  • KONG, Xianqi
    Dollard-des-Ormeaux, Québec H9B 3J7 (CA)
  • CHEN, Gang
    Suzhou, Jiangsu 215000 (CN)
  • LU, Jiasheng
    Shanghai 201702 (CN)
  • ZHANG, Qiguo
    Suzhou, Jiangsu 215000 (CN)
  • CHEN, Dawei
    Suzhou, Jiangsu 215000 (CN)
  • ZHU, Xingwu
    Suzhou, Jiangsu 215000 (CN)

(74) Representative: Høiberg P/S 
Adelgade 12
1304 Copenhagen K
1304 Copenhagen K (DK)

   


(54) CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF